Profile
Pierre Gagnon is currently the Director at ATGen Canada, Inc. He previously worked as the Director-Global Operations & Director at NKMAX Co., Ltd. from 2009 to 2019.
Additionally, he served as the Chief Operating Officer & Executive Director at NKGen Operating Biotech, Inc. from 2021 to 2023, and as the Chief Operating Officer at NKGen Biotech, Inc. from 2021 to 2024.
Mr. Gagnon obtained his undergraduate degree from the University of Quebec.
Pierre Gagnon active positions
| Companies | Position | Start |
|---|---|---|
ATGen Canada, Inc.
ATGen Canada, Inc. Part of NKMAX Co., Ltd. (South Korea), ATGen Canada, Inc. is a company based in Laval, Canada. Sang-Woo Park has been the CEO of the company since 2013. | Director/Board Member | 01/05/2013 |
Former positions of Pierre Gagnon
| Companies | Position | End |
|---|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Chief Operating Officer | 01/09/2023 |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Chief Operating Officer | 01/06/2019 |
Training of Pierre Gagnon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Quebec
University of Quebec Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATGen Canada, Inc.
ATGen Canada, Inc. Part of NKMAX Co., Ltd. (South Korea), ATGen Canada, Inc. is a company based in Laval, Canada. Sang-Woo Park has been the CEO of the company since 2013. | |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies finished pharmaceutical products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
- Stock Market
- Insiders
- Pierre Gagnon
















